Company intelligence / Profile preview

Levisonics

New Orleans, Louisiana, United Stateslevisonics.com ↗

Ownership: Private
Development stage: Other

Overview

Levisonics has developed a novel contactless technology for single-drop blood rheology and coagulation analysis. The company received an STTR Phase I grant from the National Science Foundation to advance this innovation. No published clinical trial results yet; the product appears to be in late pre-clinical or early validation stages.

Therapeutic areas: HematologyOther
Modalities: Device (medical diagnostic platform)
Industry: Physiological Monitoring

Partnerships

Collaboration with Boston University and Tulane University researchers at founding stage

Beyond the preview

Go deeper on Levisonics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Levisonics.

Explore the full profile